Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Benchmarking CRISPR-BP34 for point-of-care melioidosis detection in low-income and middle-income countries: a molecular diagnostics study

13 Mar 2024

Abstract excerpt

BACKGROUND: Melioidosis is a neglected but often fatal tropical disease. The disease has broad clinical manifestations, which makes diagnosis challenging and time consuming. To improve diagnosis, we aimed to evaluate the performance of the CRISPR-Cas12a system (CRISPR-BP34) to detect Burkholderia pseudomallei DNA across clinical specimens from patients suspected to have melioidosis. METHODS: We conducted a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Burkholderia infections and melioidosis
Share to Complement system in diseases
Share to Research on Leishmaniasis Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38493790
DOI: 10.1016/s2666-5247(23)00378-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Benchmarking CRISPR-BP34 for point-of-care melioidosis detection in low-income and middle-income countries: a molecular diagnostics studyPMID 38493790Read ↗

Benchmarking CRISPR-BP34 for point-of-care melioidosis detection in LMIC: a molecular diagnostics studySemantic proximity Read ↗

Highly specific and sensitive detection of Burkholderia pseudomallei genomic DNA by CRISPR-Cas12aSemantic proximity Read ↗

Next-generation pathogen diagnosis with CRISPR/Cas-based detection methodsSemantic proximity Read ↗

Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosisSemantic proximity Read ↗

CRISPR Diagnostics: Advances toward the Point of CareSemantic proximity Read ↗

CRISPR-Based Programmable Nucleic Acid-Binding Protein Technology Can Specifically Detect Fatal Tropical Disease-Causing PathogensSemantic proximity Read ↗

CRISPR-Based Assays for Point-of-Need Detection and Subtyping of InfluenzaSemantic proximity Read ↗

Cutting-Edge Infectious Disease Diagnostics with CRISPRSemantic proximity Read ↗

A novel CRISPR-based malaria diagnostic capable of <i>Plasmodium</i> detection, speciation, and drug-resistance genotypingSemantic proximity Read ↗

Precise pathogen quantification by CRISPR-Cas: a sweet but tough nut to crackSemantic proximity Read ↗

The combination of RPA-CRISPR/Cas12a and Leptospira IgM RDT enhances the early detection of leptospirosisSemantic proximity Read ↗

A novel CRISPR-based malaria diagnostic capable of Plasmodium detection, species differentiation, and drug-resistance genotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.